A detailed history of Prudential Financial Inc transactions in Evolus, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 43,815 shares of EOLS stock, worth $520,522. This represents 0.0% of its overall portfolio holdings.

Number of Shares
43,815
Holding current value
$520,522
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$10.66 - $17.48 $467,067 - $765,886
43,815 New
43,815 $709,000
Q3 2022

Nov 04, 2022

SELL
$7.76 - $13.72 $2.06 Million - $3.65 Million
-266,000 Reduced 70.67%
110,420 $889,000
Q2 2022

Aug 15, 2022

BUY
$10.22 - $13.94 $3.55 Million - $4.85 Million
347,800 Added 1215.23%
376,420 $4.37 Million
Q1 2022

May 13, 2022

SELL
$5.22 - $11.78 $117,084 - $264,225
-22,430 Reduced 43.94%
28,620 $321,000
Q4 2021

Feb 14, 2022

BUY
$5.37 - $8.38 $274,138 - $427,799
51,050 New
51,050 $333,000

Others Institutions Holding EOLS

About Evolus, Inc.


  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $666M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.